| HOME >> BIOLOGY >> TECHNOLOGY |
OMAHA, Neb., Nov. 7 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:
What: Transgenomic Inc. Third Quarter 2007 Earnings Release
Conference Call
When: Wednesday, November 7, 2007 @ 5:00 p.m. Eastern
Where: http://www.transgenomic.com/events.asp?id=6
How: Live over the Internet -- Simply log on to the web at the
address above.
Contact: Investor Relations -- 402-452-5400
To access the call via telephone, call 800-895-0198 or 785-424-1053. A replay of the call will be available via telephone until 11:59pm ET on Wednesday, November 21, 2007. To access, dial 800-839-4017 or 402-220-2984.
About Transgenomic: A decade of discovery 1997 - 2007
Transgenomic is a global biotechnology company that provides unique
products and services for automated high sensitivity genetic variation and
mutation analysis. Their offerings include systems, products, discovery and
laboratory testing services to the academic and medical research, clinical
laboratory and pharmaceutical markets in the fields of pharmacogenomics and
personalized medicine. Specific offerings include WAVE(R) DHPLC Systems,
related consumables and assay kits, cytogenetics automated systems,
Transgenomic Clinical Reference Laboratory and Genomic Research Services.
Transgenomic Clinical Reference Laboratory and Genomic Research Services
utilize their technology and expertise to provide a menu of mutation
scanning tests for over 700 cancer-associated genes and more than 60
validated diagnostic tests to meet the needs of pharmaceutical and biotech
companies, research and clinical laboratories, physicians and patients. For
more information about the innovative systems, products and services
offered by Transgenomic, please visit: http://www.tra
'/>"/>
| SOURCE Transgenomic Inc. Copyright©2007 PR Newswire. All rights reserved |